Disease Domain | Count |
---|---|
Infectious Diseases | 17 |
Nervous System Diseases | 5 |
Top 5 Drug Type | Count |
---|---|
Prophylactic vaccine | 14 |
Combination vaccine | 5 |
Live attenuated vaccine | 3 |
Multivalent vaccine | 3 |
Conjugated vaccine | 3 |
Mechanism Varicella-zoster virus gH/gL inhibitors [+1] |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. China |
First Approval Date11 Apr 2024 |
Target- |
Mechanism Immunostimulants |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. China |
First Approval Date12 Sep 2023 |
Target- |
Mechanism Immunostimulants |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. China |
First Approval Date29 Jul 2021 |
Start Date22 Nov 2024 |
Sponsor / Collaborator |
Start Date20 Nov 2024 |
Sponsor / Collaborator |
Start Date01 Nov 2024 |
Sponsor / Collaborator |